Dal-Hee Min, Lemonex – Innovative DDS DegradaBALL | LSI Asia '25

Lemonex is a clinical-stage biotechnology company developing thermostable RNA vaccines and gene therapeutics using its proprietary DegradaBALL® drug delivery system. DegradaBALL® is a non-viral, porous nanoparticle platform that enables room-temperature storage and reduces systemic side effects compared to conventional lipid nanoparticles. Lemonex’s technology aims to broaden global access to RNA medicines by improving stability, safety, and ease of administration.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach